Stanton Marshall S. 4
4 · ARTIVION, INC. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
ARTIVION, INC.AORT
Stanton Marshall S.
SVP, Clinical & MD Affair
Transactions
- Sale
Common Stock
[F1]2026-02-23$37.59/sh−2,423$91,076→ 43,180 total - Sale
Common Stock
[F2]2026-02-24$35.69/sh−1,259$44,937→ 41,921 total
Footnotes (2)
- [F1]These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- [F2]These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Signature
/s/ Marshall Stanton|2026-02-25